We report on a 15-year-old male with 4-year history of hypertension and retroperitoneal masses referred to Interventional Radiology to evaluate the nature of the persistent masses and renal artery stenosis. Angiographic evaluation began with CO2aortogram during which the patient had a hypertensive response with bradycardia and arrhythmia to the intra-aortic injection of CO2. His hypertension, bradycardia, and arrhythmia responded to an intravenous nitroglycerin drip without administration of alpha or beta blockers. Due to this response and neovascularity of the mass, selective venous sampling of catecholamines and renin was performed which confirmed functioning paragangliomas and hemodynamically significant stenosis of left accessory renal artery, respectively. This is the first known case of hypertensive response to CO2 aortography in a patient with unsuspected functioning paragangliomas. We propose that patients with known or suspected diagnosis of catecholamine-secreting tumors undergoing CO2 angiography should be considered for pre-procedural treatment with alpha and beta blockage or have the appropriate medication on hand with close monitoring in the event of hypertensive response.
found to be comparable in accuracy to iodinated contrast agents [1] . One of the main advantages has its relative safety. It has no renal or hepatic toxicity even when selectively injected into the respective arterial or venous systems and is a natural byproduct of metabolism, therefore cannot cause hypersensitivity reaction [2] [3].
Pheochromocytoma is an uncommon neuroendocrine tumor originating from the chromaffin cells in the medulla of the adrenal gland that secretes excessive amounts of catecholamines. Extra-adrenal pheochromocytomas (usually described as extra-adrenal paragangliomas) originate in the ganglia of the sympathetic nervous system that also produce excessive amounts of catecholamines, predominantly norepinephrine. A pheochromocytoma may cause a hypertensive crisis. It is usually benign but can be malignant in 10% of cases. Surgical removal of the tumor can cure hypertension associated with the tumor.
Hypertensive crisis induced by intra-arterial injection of ionic contrast medium in patients with catecholamine-secreting tumors is a well-known phenomenon [4] [5] . Furthermore, certain agents, such as glucagon, have been reported to induce catecholamine release from pheochromocytomas with subsequent multi-organ injury [6] . Later studies have shown that non-ionic contrast does not have this same effect when given intravenously during CT scans [3] [6] [7] .
To our knowledge, we are reporting the first case of CO 2 angiography resulting in a hypertensive response with bradycardia and arrhythmia in a patient with catecholamine-secreting tumor.
Case Summary
A 15-year-old man was referred to Interventional Radiology for evaluation of persistent retroperitoneal masses and hypertension with suspicion for renal artery stenos is. The past medical history was notable for a history of trauma and a retroperitoneal mass suspected to be a hematoma for a period of 5 years. Initial computed tomography (CT) scan demonstrated a low attenuation 1.6 cm × 1.5 cm retroperitoneal mass causing anterior deviation of the right renal artery suspicious for compression (Figure 1(A) ). Renal ultrasound demonstrated normal kidneys bilaterally without signs of renal arterial stenosis. Further evaluation with magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA) showed an irregular contrast enhancing 2.9 cm × 2.2 cm × 1.5 cm mixed signal retroperitoneal mass that demonstrated a mass effect on the inferior vena cava and right renal artery (Figure 1(B) ). Despite elevated urine catecholamines, a subsequent iodine-131-meta-iodobenzylguanidine (MIBG) scan was negative. Due to persistence of the mass and refractory hypertension requiring multiple antihypertensive medications, the patient was referred to Interventional Radiology for the evaluation ofsuspected renal artery stenosis.
Plasma catecholamine assay performed 4 years earlier, yielded epinephrine 67 pg/mL (n, 0 -100 pg/mL), Dopamine, 108 pg/mL (n, 0 -100 pg/mL), and norepinephrine, 1405 pg/mL (n, 0 -500 pg/mL). Serum aldoste- rone was 2.6 ng/dL (n, recumbent, 1 -16 ng/dL). Urine norepinephrine was 219 µg/TV (n, 0 -100 µg/TV) and urine epinephrine was 52.4 µg/TV (n, 0.0 -20.0 µg/TV).
With the patient under general anesthesia, a 5-Fr Omni Flush catheter (Angio Dynamics, Queensbury, NY, USA) was placed in the aorta above the celiac axis from a percutaneous retrograde transfemoral arterial approach, and aortograms were performed, first with 30 cc of CO 2 and then in the anterior-posterior (AP) and left anterior-oblique (LAO) projections with Visipaque (GE Healthcare, Cork, Ireland, UK). During each of the runs, there was a moderate increase in blood pressure from baseline systolic pressures of 120 s to 145 -150 s, lasting 5 minutes, accompanied by bradycardia and transient arrhythmia. A nitroglycerin drip was started; however, the patient did not require any alpha or beta blockers. Next, a 5-Fr shepherd hook catheter (Angio Dynamics, Queensbury, NY, USA) was positioned and digital subtraction angiography (DSA) was performed, sequentially, in the right and left renal arteries, superior mesenteric artery, and finally the celiac axis. The aortograms revealed two vascular retroperitoneal tumors to the right and left of the aorta, at the level of L1-2, measuring 22 mm × 27 mm and 26 mm × 27 mm, respectively (Figure 2 Table 1 . Left renal vein renin value was 117.1 ng/mL/hour (n, 0.5 -3.5 ng/mL/hour), right renal vein renin level, 75.9 ng/mL/hour, and IVC, 91.4 ng/mL/hour. The left renal: right renal renin ratio was 1.5, lateralizing renin excess to the left kidney which is most likely due to narrowing of the left inferior accessory renal artery caused by the tumor. Normal serum catecholamine values: Epinephrine = 0 -100 pg/mL; Dopamine = 0 -100 pg/mL; Norepinephrine = 0 -500 pg/mL.
The patient subsequently underwent surgical resection of the masses at the outside hospital. The procedure was completed at an outside hospital; therefore, histology of the resected tumor is not available. It was documented as a pheochromocytoma in the patient's medical record and supported by normalization of pre-operative elevation of catecholamine following removal of the tumor. On postoperative day #7, the plasma free normetanephrine was 0.65 nmol/L (n < 0.90 nmol/L) and plasma free metanephrine was lower than 0.20 nmol/L (n, < 0.50 nmol/L). Plasma norepinephrine, epinephrine, and Dopamine were also within normal limits.
The patient has not had any headache, dizziness, sweating, or abdominal pain suggestive of recurrence of his pheochromocytoma for two years and ten months after resection of pheochromocytoma. His lab studies for catecholamines were normal. He remained normotensive.
Discussion
Since the advent of digital subtraction angiography, CO 2 has commonly been used as a safe alternative contrast agent for diagnostic angiography and endovascular procedures in patients with or without renal failure and contrast allergies. To the best of our knowledge, this is the first case of a hypertensive response to the intra-aortic injection of CO 2 for aortography in a patient with catecholamine-secreting paraganglioma.
Arteriography is infrequently performed in patients with clinical and biochemical evidence of pheochromocytoma or functioning paragangliomas (extra adrenal catecholamine-secreting tumors collectively referred to as pheochromocytoms), given the advent of safe and accurate imaging modalities such as CT and MIBG scans. However, when the diagnosis is still equivocal, angiography with venous sampling is a highly sensitive and specific test that can be employed [7] . In this case, given: CT findings, negative MIBG scan, and history of abdominal trauma; the masses were first hypothesized to be retroperitoneal hematomas therefore leading to a delay in the correct diagnosis and treatment. Regardless of location, pheochromocytomas are usually hypervascular tumors exhibiting neovascularity and tumor stain. The cystic nature of the tumor or central necrosis of the tumor can demonstrate a central avascular zone surrounded by a dense rim of contrast accumulation, giving a "ring sign". Functional paragangiomas may be found in chromaffin tissue throughout the body including; along the sympathetic chain, in the neck and thorax, along the wall of urinary bladder, the organ of Zuckerkandl (located inferior to the origin of the inferior mesenteric artery), and pelvis. High local levels of catecholamines can be found in the adrenal and renal veins and along the IVC, depending on the location of the tumors [8] . Generally, extra-adrenal pheochromocytomas secrete predominantly dopamine and norepinephrine, whereas adrenal pheochromocytomas secrete epinephrine. Given the extensive yet equivocal workup the patient received, adrenal and renal vein sampling was performed to determine the diagnosis of pheochromocytoma. The normalization of catecholamine levels 7 days post operatively and resolution of persistent hypertension further confirmed the diagnosis.
Hypertensive crisis induced by ionic contrast material administered intra-arterially or intravenously, in patients with pheochromocytomas is a well-known phenomenon [4] [5] . Furthermore, certain agents, such as glucagon, have been reported to induce catecholamine release from pheochromocytomas with subsequent multi-organ injury during CT [6] . In patients with pheochromocytoma of the urinary bladder, an increase in intravesical pressure during micturition can also lead to catecholamine release and hypertensive symptoms [9] . When angiography is performed in unsuspected cases of pheochromocytomas, using contrast materials may cause hypertension. The exact mechanism for this is unknown and may be due to either contrast-induced catecholamine release or release due to arterial pressure changes from contrast injection. Studies have shown that non-ionic contrast does not have this same effect when given intravenously during CT scans; however, there are no studies regarding the safety of non-ionic contrast in angiography [10] [11] . Pre-procedural treatment with alpha blockers has been used during ionic and non-ionic contrast studies to prevent hyperadrenergic crisis, though there have been reports of breakthrough symptoms. Phenoxybenzamine, a non-selective, irreversible alpha antagonist is commonly used; however it requires the administration of a beta adrenergic antagonist to prevent reflex tachycardia [12] [13] . Doxazosinemesylate, a α1-selective alpha blocker, has also been used more recently and does not cause the same post-procedural hypotension noted with phenoxybenzamine [14] . During the patient's hypertensive response with bradycardia and arrhythmia to CO 2 angiography, a nitroglycerin drip was used successfully without the need for an alpha or beta blockade. Despite this, we believe that the standard protocol for treatment of hypertensive crisis following contrast administration, as mentioned above, should be on hand prior to performing the procedure.
To our knowledge, there have been no studies describing the safety of CO 2 angiography in diagnosing catecholamine-secreting tumors. Given its relative safety as a contrast agent as evidenced by its use in patients with renal failure or contrast allergies, it would be assumed that CO 2 angiography would not induce a hyperadrenergic response, yet this case shows that it is possible. The rare occurrence of this complication may be a result of a relatively low utilization of CO 2 in comparison to iodinated contrast when performing angiography and venous sampling, or the high accuracy of CT in diagnosing these tumors leading to a small number of angiographic testing overall.
Due to the potential neurotoxicity and coronary ischemia, CO 2 should not be used in the arterial circulation above the diaphragm. However, CO 2 can be safely used as an intravenous contrast agent in the venous circulation including the central veins, the IVC, the SVC, and the portal venous system. The potential complications of CO 2 as a contrast agent are air contamination resulting from incorrect use of the delivery system and pulmonary vapor lock due to the inadvertent administration of excessive volume of CO 2 .
Conclusion
In conclusion, despite the known safety of CO 2 as a contrast agent in the arterial circulation below the diaphragm, CO 2 aortography can cause a hypertensive response in patients with pheochromocytomas. We therefore propose that centers should consider pre-procedural therapy with the current standards for treatment of hyperadrenergic crisis, alpha and beta antagonists, or have the medications on hand with close patient monitoring in case of a hypertensive event.
